Cardiac toxicity of some echinocandin antifungals

Bibliography

• Cancidas [package insert]. Merck @ Co, Inc; Whitehouse Station, NJ: 2010
   Google Scholar
• Eraxis [package insert]. Pfizer, Inc; New York, NY: 2006
   Google Scholar
• Mycamine [package insert]. Astellas Pharma US, Inc; Deerfield, IL 2011
   Google Scholar
• Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60
   PubMed Web of Science ®Google Scholar
• Liu H, Zheng Q, Farley JM. Antimuscarinic actions of antihistamines on the heart. J Biomed Sci 2006;13:395-401
   PubMed Web of Science ®Google Scholar
• Stover KR, Liu H, Farley J, et al. Cardiac toxicity of azole antifungals [abstract M-452]. 49th annual interscience conference on antimicrobial agents and chemotherapy. San Francisco, CA. September 2009
   Google Scholar
• Cleary JD, Schwartz M, Rogers PD, et al. Effects of amphotericin B and caspofungin on histamine expression. Pharmacotherapy 2003;23(8):966-73
   PubMed Web of Science ®Google Scholar
• Butler WT, Bennett JE, Hill GJ II. Electrocardiographic and electrolyte abnormalities caused by amphotericin B in dog and man. Proc Soc Exp Biol Med 1964;116:857-63
   PubMed Web of Science ®Google Scholar
• Cleary JD, Hayman J, Sherwood J, et al. Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Pharmacother 1993;27:715-19
   PubMed Web of Science ®Google Scholar
• Bowler WA, Weiss PJ, Hill HE, et al. Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function. Antimicrob Agents Chemother 1992;36(11):2542-3
   PubMed Web of Science ®Google Scholar
• Danaher PJ, Cao MK, Anstead GM, et al. Reversible dilated cardiomyopathy related to amphotericin B therapy. J Antimicrob Chemother 2004;53(1):115-17
   PubMed Web of Science ®Google Scholar
• Tofukuji M, Metais C, Wang SY, et al. Clotrimazole is a potent vasodilator of the rat coronary microcirculation. J Surg Res 1998;77(1):6-10
   PubMed Web of Science ®Google Scholar
• Fearon IM, Ball SG, Peers C. Clotrimazole inhibits the recombinant human cardiac L-type Ca2+ channel alpha 1C subunit. Br J Pharmacol 2000;129(3):547-54
   PubMed Web of Science ®Google Scholar
• Tian M, Dong MQ, Chiu SW, et al. Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents. Br J Pharmacol 2006;147(3):289-97
   PubMed Web of Science ®Google Scholar
• Tunctan B, Altug S, Uludag O, Abacioglu N. Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. Life Sci 2000;67(19):2393-401
   PubMed Web of Science ®Google Scholar
• Phillips JA, Marty FM, Stone RM, et al. Torsades de pointes associated with voriconazole use. Transplant Infect Dis 2007;9(1):33-6
   PubMed Web of Science ®Google Scholar
• Cleary JD, Stover KR, Farley J, et al. Cardiac toxicity of azole antifungals. Pharmacol Pharm 2013;4:362-8
   Google Scholar
• Food and Drug Administration. Adverse Events Reporting System (AERS). 2011. Available from: www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm [Accessed 10 January 2012]
   Google Scholar
• Hindahl CB, Wilson JW. Flash pulmonary oedema during anidulafungin administration. J Clin Pharm Ther 2012;37:491-3
   PubMed Web of Science ®Google Scholar
• Fink M, Zerlauth U, Kaulfersch C, et al. A severe case of haemodynamic instability during anidulafungin administration. J Clin Pharm Ther 2013;38:241-2
   PubMed Web of Science ®Google Scholar
• Gussak I, Litwin J, Kleiman R, et al. Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development. J Electrocardiol 2004;37(1):19-24
   PubMed Web of Science ®Google Scholar
• Figueredo VM. Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart. Am J Med 2011;124:480-8
   PubMed Web of Science ®Google Scholar
• Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 2011;50:940-50
   PubMed Web of Science ®Google Scholar
• Guo L, Dong Z, Guthrie H. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates. J Pharmacol Toxicol 2009;60:130-51
   PubMedGoogle Scholar
• Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R. Isolated heart perfusion according to Langendorff- still viable in the new millennium. J Pharmacol Toxicol 2007;55:113-26
   PubMedGoogle Scholar
• Ahmad SR, Singer SJ, Leissa BG. Congestive heart failure associated with itraconazole. Lancet 2001;357(9270):1766-7
   PubMed Web of Science ®Google Scholar
• Valen G, Skjelbakken T, Vaage J. The effects of exogenous histamine in isolated rat hearts. Mol Cell Biochem 1995;146(1):55-61
   PubMed Web of Science ®Google Scholar
• Walker DB. Serum chemical biomarkers of cardiac injury for nonclinical safety testing. Toxicol Pathol 2006;34(1):94-104
   PubMed Web of Science ®Google Scholar
• Kaasik A, Safiulina D, Zharkovsky A, Veksler V. Regulation of mitochondrial matrix volume. Am J Physiol Cell Physiol 2007;292:C157-63
   Google Scholar